Zero Candida Begins Prototype Production of AI-Enabled Therapeutic Device ZC-001

October 21, 2025
Zero Candida Technologies has completed the design freeze and started prototype production of its AI-driven therapeutic device ZC-001 for treating Vulvo-Vaginal Candidiasis, with 50 units expected by early 2026.

Zero Candida Technologies, Inc. has completed the design freeze and started prototype production of its ZC-001 therapeutic device, announced in a press release. The company will produce 50 prototype units, expected to be completed by the first quarter of 2026.

The ZC-001 device integrates blue light therapy, targeted drug delivery, and wireless diagnostics to provide personalized treatment for Vulvo-Vaginal Candidiasis (VVC). The design freeze finalizes specifications for both the device and its SMART docking and charging case.

Key features include a docking system for automatic alignment and sterilization, wireless connectivity for encrypted data transfer, light indicators for user feedback, and medical-grade materials for comfort and biocompatibility. The device is designed for at-home use with real-time data transmission to enable physician monitoring and AI-driven analytics.

According to the company, the modular design of ZC-001 will support scalable manufacturing and potential adaptation for other gynecologic applications.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Life Sciences

10/21
Infosys Wins £1.2 Billion NHS Contract for New Workforce Management System
10/21
emtelligent Launches Integrated Medical Language Engine for Healthcare Data Processing
10/21
Breakthrough Genomics Unveils AI Tools and Largest Literature Database at ASHG 2025
10/21
Lecturio Acquires SimTutor to Expand Digital Healthcare Training Tools
10/21
DeepMind AI Identifies Senhwa Drug Candidate for Cancer Immunotherapy

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Trend report

Cybersecurity Trends Report 2025

Netwrix

The Cybersecurity Trends Report 2025 by Netwrix Research Lab provides insights into how organizations are adapting their cybersecurity strategies amidst growing AI adoption. The report, based on a survey of 2,150 IT professionals from 121 countries, highlights key trends such as the increase in hybrid IT environments, AI-driven security challenges, and the rising costs of security incidents.

Read more

You May Also Like